lamivudine and zidovudine (72865-144)

Drug Facts

Product Profile

Brand Name lamivudine and zidovudine

Generic Name lamivudine and zidovudine

Labeler xlcare pharmaceuticals, inc

Dosage Form TABLET, FILM COATED

Routes

ORAL

Active Ingredients

lamivudine 150 mg/1, zidovudine 300 mg/1

Manufacturer

XLCare Pharmaceuticals, Inc

Identifiers & Regulatory

Product NDC 72865-144

Product ID 72865-144_f26f80c3-6ad3-2c78-e053-2995a90a7783

Product Type HUMAN PRESCRIPTION DRUG

Marketing Category ANDA

Application Number ANDA203259

Listing Expiration 2026-12-31

Marketing Start 2020-04-17

Pharmacologic Class

Established (EPC)

hepatitis b virus nucleoside analog reverse transcriptase inhibitor [epc] human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor [epc]

Mechanism of Action

nucleoside reverse transcriptase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72865144

Hyphenated Format 72865-144

Supplemental Identifiers

RxCUI

200082

UPC

0372865144602

UNII

2T8Q726O95 4B9XT59T7S

NUI

N0000175656 N0000175462 N0000009947

Packaging Origin

Original Packager

true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name lamivudine and zidovudine (source: ndc)

Generic Name lamivudine and zidovudine (source: ndc)

Application Number ANDA203259 (source: ndc)

Routes

ORAL

source: ndc

Resolved Composition

Strengths

150 mg/1
300 mg/1

source: ndc

Packaging

60 TABLET, FILM COATED in 1 BOTTLE (72865-144-60)

source: ndc

Packages (1)

72865-144-60 60 TABLET, FILM COATED in 1 BOTTLE (72865-144-60)

Ingredients (2)

lamivudine (150 mg/1) zidovudine (300 mg/1)

Linked Drug Pages (1)

LAMIVUDINE AND ZIDOVUDINE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["ORAL"], "spl_id": "f26f80c3-6ad3-2c78-e053-2995a90a7783", "openfda": {"nui": ["N0000175656", "N0000175462", "N0000009947"], "upc": ["0372865144602"], "unii": ["2T8Q726O95", "4B9XT59T7S"], "rxcui": ["200082"], "spl_set_id": ["55520835-0f24-4e52-af8c-d65841ccaba7"], "pharm_class_epc": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["XLCare Pharmaceuticals, Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (72865-144-60)", "package_ndc": "72865-144-60", "marketing_start_date": "20200417"}], "brand_name": "LAMIVUDINE AND ZIDOVUDINE", "product_id": "72865-144_f26f80c3-6ad3-2c78-e053-2995a90a7783", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "72865-144", "generic_name": "lamivudine and zidovudine", "labeler_name": "XLCare Pharmaceuticals, Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LAMIVUDINE AND ZIDOVUDINE", "active_ingredients": [{"name": "LAMIVUDINE", "strength": "150 mg/1"}, {"name": "ZIDOVUDINE", "strength": "300 mg/1"}], "application_number": "ANDA203259", "marketing_category": "ANDA", "marketing_start_date": "20200417", "listing_expiration_date": "20261231"}